drugset
drugset / Trial / NCT05648266

Serratus Plane Block After Minimally Invasive Mitral Valve Repair

NCT05648266 ↗

Completed 78 enrolled University Medical Center Hamburg-Eppendorf
RandomizedParallel-groupTriple-blindSupportive care

Summary

Patients undergoing minimally invasive mitral valve reconstruction via small thoracotomy are randomized into two groups. The intervention group receives serratus anterior plane block after minimally invasive mitral-valve reconstruction, following 48h infusion with ropivacaine 2% continually. The control group receives a placebo pump without infusion. Primary endpoints are perceived pain using a numeric pain rating scale and opioid consumption during the hospital stay.

Timeline

Start
2022-04-01
Primary completion
2024-07-01
Completion
2024-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ropivacaine Other / unclassified 0.2 % —

Indications

No indication recorded.